Podcast: BMS and Bird & Bird on doing major deals in a pandemic

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Podcast: BMS and Bird & Bird on doing major deals in a pandemic

Sponsored by

twobirds-400px.jpg
 L to R: Henry Hadad, James Baillieu, Sally Shorthose

Max Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work

In the last 10 months, we have all become accustomed to working remotely and doing things differently. For lawyers, one of the impacts has been on major deals, particularly those with a cross-jurisdictional focus.

In Managing IP’s latest podcast, panellists from Bristol Myers Squibb and Bird & Bird share their thoughts on whether efficiency has increased, if we have said goodbye to paper for good, and whether we are in a licensor or licensee market. 

To learn more about completing deals in a pandemic, and for a preview of the year ahead, check out our 40-minute podcast by clicking on the link above.

more from across site and SHARED ros bottom lb

More from across our site

Matthew Cassie becomes the tenth partner to join the firm’s London outpost, and the second since it opened its new headquarters in May this year
A&O Shearman and Fish & Richardson invested in German talent, meanwhile, major firms have assembled for an on the merits case pitting KeeeX against OpenAI and Adobe
Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Gift this article